Atrys Health registers EUR 201.6m revenue in 2023, up 27.3% over 2022
Atrys Health registra ingresos de EUR 201,6m en 2023, un 27,3% más que en 2022
Intel ID : 389373
Relevant Documents
| Press Release | 27 Mar 2024 | Atrys_Health_Nota_de_Prensa_2024.pdf | ES |
|
| Intel ID | 389373 | ||
| Value | EUR 201,60m | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Atrys Health
(31 Dec 2023) |
Revenue: EUR 207,00m EBITDA: EUR 28,51m Net Debt: EUR 205,10m People: 2062 |
||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.03.03 Diagnostic, Imaging & Laboratory Services (Primary) 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.03 Diagnostic, Imaging & Laboratory Services 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.